Cargando…
Limited Promiscuity of HLA-DRB1 Presented Peptides Derived of Blood Coagulation Factor VIII
The formation of inhibitory antibodies directed against coagulation factor VIII (FVIII) is a severe complication in the treatment of hemophilia A patients. The induction of anti-FVIII antibodies is a CD4(+) T cell-dependent process. Activation of FVIII-specific CD4(+) T cells is dependent on the pre...
Autores principales: | van Haren, Simon D., Wroblewska, Aleksandra, Herczenik, Eszter, Kaijen, Paul H., Ruminska, Aleksandra, ten Brinke, Anja, Meijer, Alexander B., Voorberg, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828219/ https://www.ncbi.nlm.nih.gov/pubmed/24244658 http://dx.doi.org/10.1371/journal.pone.0080239 |
Ejemplares similares
-
Comparative profiling of HLA-DR and HLA-DQ associated factor VIII peptides presented by monocyte-derived dendritic cells
por: Peyron, Ivan, et al.
Publicado: (2018) -
Mass spectrometry-assisted identification of ADAMTS13-derived peptides presented on HLA-DR and HLA-DQ
por: Hrdinová, Johana, et al.
Publicado: (2018) -
Human Leukocyte Antigen (HLA)-DRB1*15:01 and HLA-DRB5*01:01 Present Complementary Peptide Repertoires
por: Scholz, Erika Margaret, et al.
Publicado: (2017) -
HLA DRB101 and macrophagic myofasciitis
por: Guis, S, et al.
Publicado: (2003) -
Association of HLA-DRB1*11 and HLA-DRB1*12 gene polymorphism with COVID-19 in Burkina Faso
por: Ouedraogo, Alfred Rakissida, et al.
Publicado: (2023)